𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

✍ Scribed by Hess, G.; Herbrecht, R.; Romaguera, J.; Verhoef, G.; Crump, M.; Gisselbrecht, C.; Laurell, A.; Offner, F.; Strahs, A.; Berkenblit, A.; Hanushevsky, O.; Clancy, J.; Hewes, B.; Moore, L.; Coiffier, B.

Book ID
118208167
Publisher
American Society of Clinical Oncology
Year
2009
Tongue
English
Weight
155 KB
Volume
27
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

53 POSTER A phase II, multicenter, rando
53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin®) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva®) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer
✍ R. Herbst; V. O'Neill; L. Fehrenbacher; C. Belani; P. Bonomi; L. Hart; O. Melnyk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB